D-Amino acid mutation of PMI as potent dual peptide inhibitors of p53-MDM2/MDMX interactions

被引：12

作者：

Li, Xiang ^{[1
,2
]}

Liu, Chao ^{[1
]}

Chen, Si ^{[1
]}

Hu, Honggang ^{[1
]}

Su, Jiacan ^{[3
]}

Zou, Yan ^{[1
]}

机构：

[1] Second Mil Med Univ, Dept Organ Chem, Coll Pharm, Shanghai 200433, Peoples R China

[2] Univ Maryland, Inst Human Virol, Sch Med, 725 West Lombard St, Baltimore, MD 21201 USA

[3] Second Mil Med Univ, Changhai Hosp, Shanghai 200433, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2017年 / 27卷 / 20期

关键词：

PMI; P53; MDM2/MDMX; D-Amino acid; Peptides; Tumor; P53; MDM2; CANCER; THERAPY;

D O I：

10.1016/j.bmcl.2017.09.014

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

According to the previously reported potent dual L-peptide PMI of p53-MDM2/MDMX interactions, a series of D-amino acid mutational PMI analogues, PMI-1-4, with enhanced proteolytic resistence and in vitro tumor cell inhibitory activities were reported, of which Liposome-PMI-1 showed a stronger inhibitory activity against the U87 cell lines than Nutlin-3. This D-amino acid mutation strategy may give a hand for enhancing the potential of peptide drugs. (C) 2017 Elsevier Ltd. All rights reserved.

引用

页码：4678 / 4681

页数：4

共 22 条

[1] A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53 [J].

Bernal, Federico ;

Wade, Mark ;

Godes, Marina ;

Davis, Tina N. ;

Whitehead, David G. ;

Kung, Andrew L. ;

Wahl, Geoffrey M. ;

Walensky, Loren D. .

CANCER CELL, 2010, 18 (05) :411-422

[2] Rapid identification of dual p53-MDM2/MDMX interaction inhibitors through virtual screening and hit-based substructure search [J].

Chen, Si ;

Li, Xiang ;

Yuan, Weirong ;

Zou, Yan ;

Guo, Zhongwu ;

Chai, Yifeng ;

Lu, Wuyuan .

RSC ADVANCES, 2017, 7 (16) :9989-9997

[3] Mdm2 promotes the rapid degradation of p53 [J].

Haupt, Y ;

Maya, R ;

Kazaz, A ;

Oren, M .

NATURE, 1997, 387 (6630) :296-299

[4] Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 [J].

Honda, R ;

Tanaka, H ;

Yasuda, H .

FEBS LETTERS, 1997, 420 (01) :25-27

[5] Regulation of p53 stability by Mdm2 [J].

Kubbutat, MHG ;

Jones, SN ;

Vousden, KH .

NATURE, 1997, 387 (6630) :299-303

[6] CANCER - P53, GUARDIAN OF THE GENOME [J].

LANE, DP .

NATURE, 1992, 358 (6381) :15-16

[7] D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms [J].

Liu, Min ;

Li, Chong ;

Pazgier, Marzena ;

Li, Changqing ;

Mao, Yubin ;

Lv, Yifan ;

Gu, Bing ;

Wei, Gang ;

Yuan, Weirong ;

Zhan, Changyou ;

Lu, Wei-Yue ;

Lu, Wuyuan .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (32) :14321-14326

[8] MDM2 AND MDMX IN CANCER AND DEVELOPMENT [J].

Marine, Jean-Christophe .

CANCER AND DEVELOPMENT, 2011, 94 :45-75

[9] MDMX: from bench to bedside [J].

Marine, Jean-Christophe W. ;

Dyer, Michael A. ;

Jochemsen, Aart G. .

JOURNAL OF CELL SCIENCE, 2007, 120 (03) :371-378

[10] Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development [J].

Migliorini, D ;

Denchi, EL ;

Danovi, D ;

Jochemsen, A ;

Capillo, M ;

Gobbi, A ;

Helin, K ;

Pelicci, PG ;

Marine, JC .

MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) :5527-5538

← 1 2 3 →